Feasibility of Administering Anti-CD45 Iodine (131I)...

Biology of Blood and Marrow Transplantation 2020 / 03 Vol. 26; Iss. 3

Feasibility of Administering Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] for Targeted Conditioning in Older Patients with Active, Relapsed or Refractory AML without Lead-Lined Rooms: Ongoing Phase III Sierra Trial Experience at 6 Study Sites

Nath, Rajneesh, Chu, Bae, Chen, Lingyun, Sadeghi, Amir, Senglaub, Todd, Kaiser, Leo, Saganich, Christopher, Zgaljardic, Michael, Rutar, Frank, Harling, Sean, Liang, Qing, Hari, Parameswaran, van Besie
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2019.12.687
Date:
March, 2020
File:
PDF, 67 KB
2020
Conversion to is in progress
Conversion to is failed